MIP Versus PCNL for Kidney Stone Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Manoj Monga, M.D.
UCSD Medical Center, San Diego
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of British Columbia
Vancouver, British Columbia, Canada
- Mayo Clinic
Phoenix, Arizona, United States
- University of California, San Diego, Medical Center
San Diego, California, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Ohio State Unversity
Columbus, Ohio, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jan 2021
- Primary completion
- 7 Jun 2024
- Completion
- 7 Jun 2024
- Last update posted
- 27 Mar 2025
- Registered enrollment
- 75
- Registry id
- NCT04767919
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.